Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the ...
A novel strategy that combines computational and experimental approaches has allowed researchers at Baylor College of ...
Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development ...
The skin over a fresh wound might not look like much. In some animals, though, that thin covering becomes command central for ...
Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ligand-conjugated vectors, today announces it will deliver two poster presentations at ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Cheryl Cox, MHA, Operations Director ...
Scientists mapped human brain development in Down syndrome at a cellular level, discovering that stem cells "rush" to become ...
Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...
Can humans regrow limbs? Researchers find SP6 and SP8 genes are vital for regeneration in axolotls and mice, creating a viral ...
Study helps lay the foundations for a future of “smart” tissue therapeutics that can be scaled to a patient’s needs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results